Oak review
A flat, all-dose compounded price with an oral option and a genuinely thorough intake — undercut by a headline that isn't the real month-to-month number and terms that lock you in hard once the box ships.
From $119/mo (12-month plan)
This review draws on the provider’s public pricing, terms and disclosures. No one on this desk is your clinician.
Oak at a glance
- Semaglutide
- From $119/mo (12-month plan)
- Tirzepatide
- From $185/mo (12-month plan)
- Coverage
- 45+ states (exclusions not published)
- Brand-name
- Compounded only
How we scored Oak
Each score comes out of Oak's published pricing, disclosures and oversight, and the six combine into the 71/100 Editors' Rating on our weighted six-factor framework. A commission never changes a provider's score.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the best we track — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Primary source
- Oak's own site
$119 and $185 are 12-month-plan rates, the same at every dose; what a single month costs appears only at checkout. Forty-five-plus states with exclusions unpublished, and neither the pharmacy nor the medical director is named.
What to expect when you sign up
We walked Oak's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
These signup observations are from . The flow and offers may have changed; use the current pricing and terms in this review.
- 1Oak's pages price semaglutide from $119/mo and tirzepatide from $185/mo, both on a 12-month plan, one price at every dose
- 2An unusually thorough async intake screens personal and family thyroid-cancer history (MTC/MEN-2) and requires a full-body photo upload
- 3A doctor reviews the questionnaire — same-day approval, no required video visit
- 4The month-to-month price only appears at checkout
What we noticed
- The 'from' prices are 12-month-plan rates; Oak shows what a shorter plan costs only at checkout
- The intake genuinely screens thyroid-cancer risk (MTC/MEN-2), which not every competitor does
- The terms are strict: no refunds once medication ships, plus binding arbitration and a class-action waiver
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $119 | 12-month plan (from), all dosesOak's own page: 'From $119/mo on a 12-month plan.' Shorter plans are available; Oak shows their price only at checkout. |
| Compounded tirzepatide | $185 | 12-month plan (from), all dosesOak's own page: 'From $185/mo on a 12-month plan.' The month-to-month price shows only at checkout. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Oak's public disclosures at last review and change often; confirm the current number on Oak's own site.
Prices move. Check today's number for your dose.See plans at Oak
What we like
- Flat 'one price, all dosages' structure on both molecules, with an oral option
- An unusually thorough intake that screens thyroid-cancer risk (MTC/MEN-2)
- Async, same-day approval with no required video visit; LegitScript seal shown
The caveats
- The 'from $119/$185' prices are 12-month-plan rates — the month-to-month price shows only at checkout
- No refunds once medication ships, plus binding arbitration and a class-action waiver
- Doesn't name its compounding pharmacy or a medical director; a BC address sits behind a Delaware entity
- Serves ~45 states (exclusions not published) and offers no maternal framing
Weighed the likes and the caveats? Look at the plans yourself.See plans at Oak
Oak in short
Oak doesn't price as one simple monthly rate, which makes it harder to compare at a glance. Its strongest marks from us are for value for a family budget; its weakest are for flexibility to pause or cancel.
What you'll pay at Oak
- Compounded semaglutide — 12-month plan (from), all doses: $119/mo
- Compounded tirzepatide — 12-month plan (from), all doses: $185/mo
That figure is a 12-month rate, not a month-to-month one, so it is not directly comparable to the roughly $196/month typical price among the providers we've reviewed — you are committing to the full term to reach it. The price is the same at every dose, so the bill doesn't grow as you step up.
What's included: the clinician consult and the medication.
What Oak prescribes
Oak prescribes semaglutide and tirzepatide — the two GLP-1 medications with the strongest evidence. If insulin resistance is part of your story (PCOS, a history of gestational diabetes), tirzepatide is often the better fit, and you won't need a new provider to try it. These are compounded versions from a licensed pharmacy, which keeps the price down, but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free option is on the menu, which appeals if injections have been the sticking point. The catch is evidence: oral and sublingual versions of these peptides are much less studied than the injectable ones.
Before you start the intake
The price only appears once you're into the intake, so set aside time to get that far before you can compare.
Similar providers
Other providers we've reviewed that offer semaglutide and tirzepatide:
- Omnia TeleHealth — no comparable monthly rate confirmed, semaglutide and tirzepatide
- form by GBY — $159/mo, semaglutide and tirzepatide, same price at every dose, brand-name pens available
- No BS RX — $149/mo, semaglutide and tirzepatide, same price at every dose
Is Oak right for you?
Worth a look if…
- You may want to switch between semaglutide and tirzepatide later on.
Probably not for you if…
- You specifically want an FDA-approved brand pen with its own pregnancy and breastfeeding labeling.
- You're breastfeeding or trying to conceive and want a prescriber to weigh in on timing — see CoreAge Rx, a featured partner.
Can you trust it?
With any compounded GLP-1, ask which licensed pharmacy fills the prescription and what exactly is in the vial. Our methodology shows how oversight feeds the score.
Tell your own clinician if you are pregnant, breastfeeding or trying to conceive before starting treatment. Using medication for weight loss is not recommended while pregnant. Breastfeeding decisions require the specific product’s labeling and an individual assessment, rather than a blanket rule across every GLP-1 formulation.
What to ask Oak first
- What will I pay each month, and does that change as the dose goes up?
- If I get pregnant or start trying, how do I pause, and will I be charged meanwhile?
The bottom line
Without one all-in monthly price, Oak is hard to judge on cost. Its strongest point with us is value for a family budget; get a quote before you weigh it against the rest. CoreAge Rx, a featured partner, is worth a side-by-side look before you decide.
The bottom line for mothers
Best for: Mothers drawn to a flat all-dose price and an oral option who will price the true single-month rate — not the headline — and can live with strict, no-refund terms.
Alternatives to Oak
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge RxCoreAge RxFeatured partner
The one program on our list whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit MadeMed
A flat-rate compounded program with no dose-based price creep — $239/mo semaglutide, $399/mo tirzepatide on the standard quarterly plan — but it's only licensed in 23 states, so check the list before you get attached to the price.
- Visit Live Vital
Semaglutide and tirzepatide sold as 10-week protocols — $299 and $549, about $130 and $238 a month — from a broader peptide platform where a named physician personally reviews every intake, though the advertised per-month figures are lower than the protocol totals work out to.
Providers like Oak
Keep comparing Oak
Head-to-head & alternatives
Ranked boards
- The 2026 guide to the best GLP-1 for moms
- Best GLP-1 for women — PCOS & menopause
- Best GLP-1 for first-timers & beginners
- Cheapest GLP-1 without insurance
- Best GLP-1 after baby — postpartum providers ranked
- Best GLP-1 with insurance & coverage help
- Best GLP-1 providers for PCOS
- Best GLP-1 for perimenopause & menopause
- Cheapest tirzepatide online, month to month
- Cheapest semaglutide online, month to month
Oak, answered
- Is Oak's 'from $119' the price I'll actually pay?
- Not month to month. Oak's own pages say the $119 semaglutide and $185 tirzepatide prices are 12-month-plan rates, the same at every dose. Shorter plans exist, but Oak shows their price only at checkout. For a mother budgeting honestly, get the month-to-month number on the checkout screen and compare it — not the headline — before you enroll.
- What should a mother know about Oak's cancellation terms?
- This is the part to read twice. Oak markets 'no subscriptions,' but its terms state that once medication ships, refunds are not issued under any circumstances, and enrollment includes binding arbitration and a class-action waiver. For a mother whose plans can shift — a nursing stretch, a pregnancy, a change in priorities — that's a rigid place to be locked in. Weigh it against a provider with a cancellation path you can actually find.
- Does Oak screen for the risks that matter?
- To its credit, yes — more than some. Oak's async intake screens personal and family history of medullary thyroid cancer and MEN-2 (the GLP-1 black-box contraindication) and requires a full-body photo, which is more diligence than a bare quiz. It carries a LegitScript seal, though it doesn't name its compounding pharmacy or a medical director. As always, no GLP-1 is established as safe in pregnancy or breastfeeding — plan the timing with your clinician.
Have a question we didn't answer? Oak's team can.See plans at Oak
Pricing, states and verification reflect Oak's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.